Assessing State, Federal Legislation Alignment With Expansion of Pharmacist’s Role on Care Team
May 4th 2022Tracy Russell, senior director, State Government Affairs at CoverMyMeds, discusses her presentation at Asembia Summit 2022 on legislation aligned with the movement to expand the pharmacist’s role on the care team.
Expert: Specialty Approvals Pharmacists Should Look for on the Horizon
May 4th 2022Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, addresses his presentation on the specialty pharmaceutical pipeline, and specifically what approvals pharmacists should look for on the horizon.
Overview of the Most Significant Drugs in Specialty Pharmacy FDA Pipeline in 2022
May 3rd 2022Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses some of the more significant drugs for specialty pharmacy in the FDA pipeline this year.
Expert: Specialty Pharmacy is Changing, “Needs to Go Where the Patients Are” in the Future
November 29th 2021Ray Tancredi, RPh, MBA, divisional VP of specialty pharmacy development and brand Rx/vaccine purchasing at Walgreens, provides an analysis and overview of key specialty pharmaceuticals in development.
Empowering Women in Pharmacy to Take on More Leadership Roles
May 3rd 2019It was during the middle of the night when Suzanne Soliman, PharmD, founder of the Pharmacist Mom Group on Facebook, got the idea for her group page, which has since grown to be one of the most active on the popular social media platform, with more than 2 million posts last year alone.
Massive Change Could Be Looming for Specialty Pharmacy
May 2nd 2019During the featured session at Asembia’s Specialty Pharmacy Summit 2019, “Specialty Industry Outlook: What’s Next,†speakers Adam Fein, PhD, CEO of the Drug Channels Institute; Lisa Gill, managing director of J.P. Morgan Securities; and Doug Long, vice president of industry relations at IQVIA, explored the radical changes that could be on the horizon from potential legislation that would dramatically alter the health care industry.
Former FDA Commissioner Scott Gottlieb Talks Agency Innovation
May 2nd 2019At the Asembia Specialty Pharmacy Summit 2019, Scott Gottlieb, MD, 23rd commissioner of the FDA discussed the agency's role in rewriting the modern rules of new regulatory paradigms for a number of recent advancements in medicine.
Oncology Innovation Fueling Rapid Pipeline Growth
May 1st 2019The oncology drug pipeline has experienced rapid growth over the past decade, driven by innovation in cell therapies, immunotherapy, and precision medicine, according to a specialty pipeline update presentation at the Asembia Specialty Pharmacy Summit 2019.